Canaccord Genuity维持TransMedics Group(TMDX)买入评级

华尔街洞察
Jul 16

知名金融机构Canaccord Genuity最新发布评级报告,重申对器官移植医疗科技企业TransMedics Group(NASDAQ:TMDX)的买入评级建议。这一评估基于该公司在器官移植保存技术领域的创新优势与市场增长潜力,专业分析认为其股价仍有上行空间。相关评级决策已于2025年7月15日正式生效。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10